Press releases in 2017

17. 11. 2017 |
Novartis, Amgen and the Banner Alzheimer's Institute (BAI) announced an expanded collaboration to initiate a new trial - the Alzheimer's Prevention Initiative (API) Generation Study 2. This trial follows the ...
16. 11. 2017 |
Pharmaceutical Company Lek is the recipient for the best human resource practice award. This honour was bestowed at the HR&M conference in Slovenia that focuses on the importance of connections ...
15. 11. 2017 |
Sandoz is today staging a digital scientific event, aimed at driving access to information about appropriate use of antibiotics to healthcare officials across Central & Eastern Europe and beyond, including ...
14. 11. 2017 |
Samo Roš, Member of the Board of Management and Head Human Resources of Lek d.d., signed at today’s ceremony, held under the patronage of the President of the Republic of Slovenia ...
19. 10. 2017 |
Lek Pharmaceuticals d.d. received this year its 15th TOP 10 Education Management Award, ranking itself once again among the ten best custodians of knowledge in Slovenia. Planet GV and the ...
12. 10. 2017 |
An important part of Lek’s more than 70-year history is our responsibility for both patients and the health and safety of our employees, as well as that of the local ...
28. 9. 2017 |
Novartis has joined forces with researchers from the University of California, Berkeley, to develop new technologies for the discovery of next-generation therapeutics, pursuing the vast number of disease targets in ...
27. 9. 2017 |
On the occasion of this year’s Innovation Day, titled ''Making Dreams Come True'', the Slovenian Chamber of Commerce and Industry bestowed national awards for the most innovative companies and innovators ...
20. 9. 2017 |
Novartis announced that the European Commission (EC) approved Kisqali® (ribociclib) in combination with an aromatase inhibitor for treatment of postmenopausal women with hormone receptor positive, human epidermal growth factor receptor-2 negative ...
30. 8. 2017 |
Lek maintained their high dynamic regarding investments. Novartis earmarked almost EUR 170 million for Slovenia, bringing the total to EUR 1.9 billion over the last 14 years. This investment allowed ...
21. 8. 2017 |
Novartis and Medicines for Malaria Venture (MMV) have launched a patient trial for KAF156, a next-generation antimalarial compound with the potential to treat drug-resistant strains of the malaria parasite. The ...
25. 7. 2017 |
Sandoz today announces the expansion of a pilot project with leading charity World Child Cancer, aimed at improving access to treatment and optimizing survival outcomes for children suffering from cancer ...
11. 7. 2017 |
At its meeting, the Supervisory Board of Lek appointed new management board members on the proposal of Zvone Bogdanovski who will succeed Vojmir Urlep on August 2, 2017 in the ...
19. 6. 2017 |
Sandoz, a Novartis division, and the pioneer and global leader in biosimilars, announced today that the European Commission (EC) has approved biosimilar rituximab* for use in Europe†. Sandoz biosimilar rituximab is approved ...
24. 5. 2017 |
With yesterday’s announcement of the winners, Lek successfully concluded the seventh Regional BioCamp with the title Immunotherapy – Challenges and Opportunities. Among the 35 participating young students from nine countries, ...
22. 5. 2017 |
At this year’s seventh consecutive Regional BioCamp, organised from May 21 to 23 by Lek, the selected life-science students will, together with lecturers and mentors, research new challenges and opportunities ...
12. 5. 2017 |
Vojmir Urlep, President of the Board of Management of Lek and Novartis in Slovenia, received at the Slovenian Pharmaceutical Society awards ceremony on Thursday, May 11, the Minařik Award, the highest ...
11. 5. 2017 |
Voluntary activities organized in Slovenia by Novartis as part of the global Community Partnership Day initiative, are fully underway. From April 13 to May 26, the employees will be dedicating ...
26. 4. 2017 |
Zvonko Bogdanovski, a Member of the Lek Board of Management and Cluster Head Central and Eastern Europe/CIS at Sandoz, will succeed Vojmir Urlep in the position of President of the ...
24. 4. 2017 |
The first activities within this year’s Community Partnership Days are already behind us – we have been clearing litter and general rubbish in the Kolpa river valley, tidying up the ...
19. 4. 2017 |
In the presence of Andreja Katič, Minister of Defence of the Republic of Slovenia, a ceremonial academy was held in Mengeš on the occasion of the 70th anniversary of the Volunteer ...
11. 4. 2017 |
In the presence of Miro Cerar, PhD, Prime Minister of the Republic of Slovenia, a foundation stone for the new production plant for a broad-spectrum antibiotic, one of the most ...
7. 4. 2017 |
Today, Lek organised an Open Door Day at its Prevalje site. More than 150 visitors had an opportunity to have a closer look at the production and organisation of work, ...
6. 4. 2017 |
Lek has symbolically handed over to the Firefighters Association of Slovenia a donation in the amount of 20,000 Euros, dedicated to the implementation of emergency medical training (EMT) courses for ...
24. 3. 2017 |
At yesterday’s Golden Thread Award ceremony, Lek received the prestigious Golden Practice Award. Among the 19 submissions participating, the jury recognised the uniqueness and excellence of the Bio Career Breakfast ...
23. 3. 2017 |
Sandoz held a Scientific Standalone Event “Reach Targets – Save Lives” on March 21, in Warsaw, Poland. This event aims to increase access to valuable medical information in the field ...
13. 3. 2017 |
Sandoz, a Novartis Division, announced today the three winners of the inaugural Healthcare Access Challenge (Sandoz HACk). The winners, chosen by a panel of judges at the Wired Health 2017 event in ...
8. 2. 2017 |
Sandoz, a Novartis division, is proud to announce that it has been officially certified by the Top Employers Institute for its exceptional employee offerings in Europe.
27. 1. 2017 |
Lek d.d. and Kuehne + Nagel d.o.o. will start to cooperate in warehousing and logistics in 2018. With this Lek will consolidate their logistics, improve their services, expand capacities and ...
27. 1. 2017 |
Novartis has confirmed the expansion of the production of broad-spectrum antibiotic at the Prevalje Penicillin Site. The investment will significantly increase the existing capacity and will be ongoing over several ...
6. 1. 2017 |
In accordance with the decision Novartis announced in October 2015 about the divestment of Hotel Lek and in line with the sale process Novartis has decided on the strategic buyer ...
3. 1. 2017 |
For the second year in a row, Lek's business unit Biopharmaceuticals Mengeš has organised Bio Career Breakfast, an event, to which highly educated Slovenian natural science experts working or studying ...